Detalhe da pesquisa
1.
Restriction of HIV-1 Escape by a Highly Broad and Potent Neutralizing Antibody.
Cell
; 180(3): 471-489.e22, 2020 02 06.
Artigo
Inglês
| MEDLINE | ID: mdl-32004464
2.
A phase 2 clinical trial of combined BRAF/MEK inhibition for BRAFV600E-mutated multiple myeloma.
Blood
; 141(14): 1685-1690, 2023 04 06.
Artigo
Inglês
| MEDLINE | ID: mdl-36608320
3.
Early detection of multiple myeloma: A first step towards a screening programme.
Br J Haematol
; 204(2): 393-394, 2024 02.
Artigo
Inglês
| MEDLINE | ID: mdl-38168005
4.
Long-term remission in a patient with relapsed Richter's transformation treated with CD19-directed chimeric antigen-receptor T-cells after allogeneic stem cell transplantation.
Eur J Haematol
; 2024 Feb 05.
Artigo
Inglês
| MEDLINE | ID: mdl-38316549
5.
Post-transplant-cyclophosphamide and short-term Everolimus as graft-versus-host-prophylaxis in patients with relapsed/refractory lymphoma and myeloma-Final results of the phase II OCTET-EVER trial.
Eur J Haematol
; 2024 Apr 14.
Artigo
Inglês
| MEDLINE | ID: mdl-38616351
6.
Refractory multiple myeloma: Count refractory drugs, not lines of treatment!
Br J Haematol
; 202(1): 16-17, 2023 07.
Artigo
Inglês
| MEDLINE | ID: mdl-37039048
7.
Allogeneic stem cell transplant recipients admitted to the intensive care unit during the peri-transplant period have unfavorable outcomes-results of a retrospective analysis from a German university hospital.
Ann Hematol
; 101(2): 389-395, 2022 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-34668981
8.
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trial.
Am J Hematol
; 97(8): 1023-1034, 2022 08.
Artigo
Inglês
| MEDLINE | ID: mdl-35617104
9.
Safety and efficacy of intravenously administered cidofovir in adult haematopoietic cell transplant recipients: a retrospective multicentre cohort study.
J Antimicrob Chemother
; 76(11): 3020-3028, 2021 10 11.
Artigo
Inglês
| MEDLINE | ID: mdl-34324678
10.
Changes in treatment landscape of relapsed or refractory multiple myeloma and their association with mortality: Insights from German claims database.
Eur J Haematol
; 106(2): 148-157, 2021 Feb.
Artigo
Inglês
| MEDLINE | ID: mdl-32989806
11.
MOMENTUM: momelotinib vs danazol in patients with myelofibrosis previously treated with JAKi who are symptomatic and anemic.
Future Oncol
; 17(12): 1449-1458, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33423550
12.
Detection of systemic immunosuppressants in autologous serum eye drops (ASED) in patients with severe chronic ocular graft versus host disease.
Graefes Arch Clin Exp Ophthalmol
; 259(1): 121-128, 2021 Jan.
Artigo
Inglês
| MEDLINE | ID: mdl-32812133
13.
Clinical and pharmacoeconomic evaluation of antifungal prophylaxis with continuous micafungin in patients undergoing allogeneic stem cell transplantation: A six-year cohort analysis.
Mycoses
; 64(4): 437-444, 2021 Apr.
Artigo
Inglês
| MEDLINE | ID: mdl-33354800
14.
Brentuximab vedotin for recurrent Hodgkin lymphoma after allogeneic hematopoietic stem cell transplantation: A report from the EBMT Lymphoma Working Party.
Cancer
; 125(1): 90-98, 2019 01 01.
Artigo
Inglês
| MEDLINE | ID: mdl-30351488
15.
Sequential therapy for patients with primary refractory acute myeloid leukemia: a historical prospective analysis of the German and Israeli experience.
Haematologica
; 104(9): 1798-1803, 2019 09.
Artigo
Inglês
| MEDLINE | ID: mdl-30733263
16.
Imatinib dose reduction in major molecular response of chronic myeloid leukemia: results from the German Chronic Myeloid Leukemia-Study IV.
Haematologica
; 104(5): 955-962, 2019 05.
Artigo
Inglês
| MEDLINE | ID: mdl-30514803
17.
Rationale and design of the German-speaking myeloma multicenter group (GMMG) trial HD6: a randomized phase III trial on the effect of elotuzumab in VRD induction/consolidation and lenalidomide maintenance in patients with newly diagnosed myeloma.
BMC Cancer
; 19(1): 504, 2019 May 28.
Artigo
Inglês
| MEDLINE | ID: mdl-31138244
18.
Multiple drug combinations of bortezomib, lenalidomide, and thalidomide for first-line treatment in adults with transplant-ineligible multiple myeloma: a network meta-analysis.
Cochrane Database Syst Rev
; 2019(11)2019 11 25.
Artigo
Inglês
| MEDLINE | ID: mdl-31765002
19.
Reduced Relapse Incidence with FLAMSA-RIC Compared with Busulfan/Fludarabine for Acute Myelogenous Leukemia Patients in First or Second Complete Remission: A Study from the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Biol Blood Marrow Transplant
; 24(11): 2224-2232, 2018 11.
Artigo
Inglês
| MEDLINE | ID: mdl-30009981
20.
Incidence of Second Primary Malignancies after Autologous Transplantation for Multiple Myeloma in the Era of Novel Agents.
Biol Blood Marrow Transplant
; 24(5): 930-936, 2018 05.
Artigo
Inglês
| MEDLINE | ID: mdl-29339268